SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-21-000196
Filing Date
2021-10-06
Accepted
2021-10-06 06:03:02
Documents
1
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-100621.htm 6-K 27586
  Complete submission text file 0001395064-21-000196.txt   28544
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 211308771
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences